Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 509, pseudogene (RN7SL509P)** is a **pseudogene** in the human genome. Pseudogenes are gene copies that generally have lost the ability to encode functional proteins due to mutations or genomic rearrangements. RN7SL509P is classified as a processed pseudogene related to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP). While functional 7SL RNA plays a central architectural and regulatory role in the SRP complex involved in protein targeting to membranes, **RN7SL509P itself does not produce functional RNA or protein and is not considered a therapeutic target**[1][2][5]. Pseudogenes in general may sometimes regulate gene expression post-transcriptionally or function as sources of non-coding RNA, but there is no specific evidence linking RN7SL509P to any biological process, disease, or drug response. It is **not a receptor, enzyme, transporter, nor associated with any druggable mechanism**[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 509, pseudogene (RN7SL509P).